Hantavirus vaccine in 2026?
Part of: Hantavirus vaccine in 2026? . Crowd probability estimates from prediction markets, not financial advice.
Probability history
Gridlines at 25, 50 and 75 percent. History covers the recorded price path of the YES outcome.
Resolution criteria
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Source: Polymarket via the public gamma API, synced by Kresmion. Last updated 2026-07-15 00:23 UTC. Trade on the venue itself: this page is research context, not an order book. Percentages are YES prices and can move fast.